Benitec Biopharma Inc. (BNTC) vs Avita Medical Inc. (RCEL)

A side-by-side comparison of Benitec Biopharma Inc. and Avita Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNTC vs RCEL

growth of $100 · dividends reinvested · last 10y
BNTC -97.4% (-30.5%/yr)RCEL +79.1% (+6.0%/yr)RCEL compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$3$179
BNTC RCEL

BNTC vs RCEL: by the numbers

  • •RCEL is the larger company ($319M vs $309M market cap).
  • •Both run net losses; BNTC's is the smaller (0.00% vs -56.96% net margin).

Metrics side by side

Valuation

MetricBNTCRCEL
P/S ratioN/A4.22
P/B ratio1.75N/A

Profitability

MetricBNTCRCEL
Gross margin0.00%81.56%
Operating margin0.00%-59.40%
Net margin0.00%-56.96%
ROE-25.73%N/A
ROIC-28.88%-136.92%

Growth (annualized)

MetricBNTCRCEL
Revenue CAGR (5Y)N/A20.94%
Total return CAGR (5Y)-31.08%-5.28%

Frequently asked

How have BNTC and RCEL total returns compared?
Over the past 10 years, BNTC delivered -30.49% and RCEL delivered 4.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.